The Effect of Children's Laughter Video on Oncology Patient

NCT07051616 | Completed

• 1 other identifier: 2025/25
• Study Type: interventional
• Target: 36
• Locations: 1 country
• Sites: 1

Brief Summary

This study was conducted to investigate the effect of video playback of children's laughter on anxiety, nausea, vomiting and fatigue levels of patients during chemotherapy

Conditions

Anxiety; Chemotherapy Effect; Laughter; Fatigue; Nausea; Vomiting

Outcome Measures

Primary Outcomes (9)

• Patient information form

  The form was designed by the researchers in two parts to assess personal characteristics and characteristics related to the disease and treatment.

  First measurement-10. minutes before the start of the patient's chemotherapy

• Spielberger State Anxiety Scale

  The scale measures the level of status anxiety of the patient with 20 questions.this form was applied in the pre-test and post-test phase

  First measurement- 5 minutes before the start of the patient's chemotherapy

• FACIT Fatigue Scale

  Developed by Singh in 2014, the scale was developed to evaluate the relationship between anemia and fatigue in cancer patients and to meet the increasing demand. This form was applied in the pre-test and post-test phase.

  First measurement- 1 minutes before the start of the patient's chemotherapy

• Physiological Parameter Follow-up Form (Heart rate-min)

  This form was created by researchers. When chemotherapy started and measured at the beginning of each hour.

  As soon as chemotherapy is started (Within first five minute)

• Physiological Parameter Follow-up Form (Respiration rate- min)

  This form was created by researchers. When chemotherapy started and measured at the beginning of each hour.

  As soon as chemotherapy is started (Within first five minute)

• Physiological Parameter Follow-up Form (oxygen saturation -SpO2%)

  This form was created by researchers. When chemotherapy started and measured at the beginning of each hour.

  As soon as chemotherapy is started (Within first five minute)

• Physiological Parameter Follow-up Form (blood pressure- mmHg)

  This form was created by researchers. When chemotherapy started and measured at the beginning of each hour.

  As soon as chemotherapy is started (Within first five minute)

• Nausea Follow-up Form

  With this form, the presence or absence of the patient's nause was questioned.Nausea was first measured at the start of chemotherapy

  As soon as chemotherapy is started (Within first five minute)

• Vomiting Follow-up Form

  With this form, the presence or absence of the patient's vomiting was questioned. Vomiting was first measured at the start of chemotherapy

  As soon as chemotherapy is started (Within first five minute)

Secondary Outcomes (24)

• Physiological Parameter Follow-up Form (Heart rate-min)

  Second measurement: 1. hour after starting chemotherapy

• Physiological Parameter Follow-up Form (Respiration rate- min)

  Second measurement: 1. hour after starting chemotherapy

• Physiological Parameter Follow-up Form (oxygen saturation -SpO2%)

  Second measurement: 1. hour after starting chemotherapy

• Physiological Parameter Follow-up Form (blood pressure- mmHg)

  Second measurement: 1. hour after starting chemotherapy

• Nausea Follow-up Form

  Second measurement: 1. hour after starting chemotherapy

Study Arms (2)

Child laughter video group

EXPERIMENTAL

Patients in this group were made to watch the laughter video prepared by the researchers at the end of the 1st and 2nd hour after the start of chemotherapy.

Behavioral: Child laughter video

Control Group

NO INTERVENTION

Participants in the control group were not subjected to any intervention other than routine practice during chemotherapy.

Interventions

Child laughter video BEHAVIORAL

1 hour after the chemotherapy treatment was started, the video monitor was placed at a height where the patient could see comfortably while lying down and the video, which was checked and prepared beforehand, was turned on full screen. The appropriate volume was adjusted and the patient was allowed to watch the video for 10 minutes without any other intervention. The video was then stopped and the etagere was removed from in front of the patient. Chemotherapy was continued. At the 2nd hour of chemotherapy, the disinfected etagere and computer were placed in a position where the patient could see them comfortably and the 2nd video was started and the patient was allowed to watch the video for 10 minutes.

Child laughter video group

Eligibility Criteria

• Age: 32 Years - 81 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Diagnosed with lymphoma (preferred to have the same type of cancer)
• Receiving the R - Chop cycle protocol as chemotherapy (This cycle was preferred because of the nausea and vomiting experienced in this protocol and the duration of the treatment is 4-5 hours) (Cleveland Clinic 2025).
• Inpatient hospitalization,
• Be over 18 years of age,
• Conscious, oriented and cooperative

You may not qualify if:

• Don't take a different cure than R - Chop,
• Visual and hearing and cognitive impairment,
• Do not have a problem that creates a communication barrier,
• Having any psychiatric illness such as depression, euphoria and taking psychiatric medication
• Refusal to participate in the study
• Other non-pharmacological methods

Sponsors & Collaborators

• Selcuk University: lead

Study Sites (1)

Sibel Küçükoğlu

Selçuklu, Akademi Mahallesi, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Anxiety Disorders; Laughter; Fatigue; Nausea; Vomiting

Condition Hierarchy (Ancestors)

Mental Disorders; Nonverbal Communication; Communication; Behavior; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Signs and Symptoms, Digestive

Study Officials

• Sibel Kucukoglu, Prof

  Selcuk University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Prof

Study Record Dates

• First Submitted: June 25, 2025
• First Posted: July 4, 2025
• Study Start: September 15, 2023
• Primary Completion: May 30, 2025
• Study Completion: May 30, 2025
• Last Updated: July 4, 2025

Record last verified: 2025-06

Locations

TU (1)